Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 4:28 pm Sale | 13G | PLUM ACQUISITION CORP. III WAR PLMJW | INTEGRATED CORE STRATEGIES (US) LLC | 0 0.000% | -1,324,566 (Position Closed) | View |
| 2024-11-12 4:19 pm Sale | 13G | VAPOTHERM INC VAPO | INTEGRATED CORE STRATEGIES (US) LLC | 0 0.000% | -490,044 (Position Closed) | View |
| 2024-11-12 4:15 pm Sale | 13G | Avid Bioservices Inc. CDMO | INTEGRATED CORE STRATEGIES (US) LLC | 880,968 1.400% | -3,359,179 (-79.22%) | View |
| 2024-11-07 4:25 pm Sale | 13G | NETSTREIT CORP NTST | INTEGRATED CORE STRATEGIES (US) LLC | 3,825,273 4.700% | -78,168 (-2.00%) | View |
| 2024-11-07 4:21 pm Sale | 13G | Embecta Corp. EMBC | INTEGRATED CORE STRATEGIES (US) LLC | 2,444,823 4.200% | -1,191,125 (-32.76%) | View |
| 2024-11-06 4:08 pm Purchase | 13G | PHINIA INC. PHIN | INTEGRATED CORE STRATEGIES (US) LLC | 2,272,842 5.400% | 2,272,842 (New Position) | View |
| 2024-11-05 4:15 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | INTEGRATED CORE STRATEGIES (US) LLC | 1,628,534 1.900% | -1,851,096 (-53.20%) | View |
| 2024-11-05 4:11 pm Sale | 13G | UTZ BRANDS, INC. CLASS A UTZ | INTEGRATED CORE STRATEGIES (US) LLC | 2,805,867 3.400% | -1,383,200 (-33.02%) | View |
| 2024-11-04 4:07 pm Sale | 13G | SUTRO BIOPHARMA INC. STRO | INTEGRATED CORE STRATEGIES (US) LLC | 2,031,745 2.500% | -1,420,080 (-41.14%) | View |
| 2024-11-01 4:05 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | INTEGRATED CORE STRATEGIES (US) LLC | 2,948,876 5.200% | 2,948,876 (New Position) | View |
| 2024-10-31 4:23 pm Sale | 13G | MAXCYTE INC. MXCT | INTEGRATED CORE STRATEGIES (US) LLC | 4,192,865 4.000% | -1,556,150 (-27.07%) | View |
| 2024-10-29 4:30 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | INTEGRATED CORE STRATEGIES (US) LLC | 2,778,525 5.200% | 1,047,636 (+60.53%) | View |
| 2024-10-16 4:43 pm Purchase | 13G | Cryoport Inc. CYRX | INTEGRATED CORE STRATEGIES (US) LLC | 3,730,516 7.500% | 913,417 (+32.42%) | View |
| 2024-10-11 4:14 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | INTEGRATED CORE STRATEGIES (US) LLC | 9,400,573 6.400% | 1,650,440 (+21.30%) | View |
| 2024-10-08 4:29 pm Purchase | 13G | ABEONA THERAPEUTICS INC NE ABEO | INTEGRATED CORE STRATEGIES (US) LLC | 2,301,628 5.300% | 882,953 (+62.24%) | View |
| 2024-10-07 4:13 pm Purchase | 13G | Accolade Inc. ACCD | INTEGRATED CORE STRATEGIES (US) LLC | 4,090,342 5.100% | 4,090,342 (New Position) | View |
| 2024-09-03 4:23 pm Purchase | 13G | Cryoport Inc. CYRX | INTEGRATED CORE STRATEGIES (US) LLC | 2,817,099 5.700% | 2,817,099 (New Position) | View |
| 2024-08-14 4:07 pm Purchase | 13G | REVIVA PHARMACEUTICALS HOLDINGS INC. RVPH | INTEGRATED CORE STRATEGIES (US) LLC | 1,563,595 5.200% | 1,563,595 (New Position) | View |
| 2024-07-02 4:20 pm Purchase | 13G | ZIMVIE INC ZIMV | INTEGRATED CORE STRATEGIES (US) LLC | 1,294,528 4.700% | 579,936 (+81.16%) | View |
| 2024-06-14 4:09 pm Purchase | 13G | GRANITE CONSTRUCTION INC GVA | INTEGRATED CORE STRATEGIES (US) LLC | 2,334,669 5.300% | 2,334,669 (New Position) | View |